Verified ProfileEN

Shiyao Group Weisheng Pharmaceutical (shijiazhuang) Co., Ltd.

Order verification — $199

Manufacturing · Manufacture of Chemical Raw Materials and Pharmaceutical Preparations

Verification dossier

Shiyao Group Weisheng Pharmaceutical (shijiazhuang) Co., Ltd. is a Chinese company based in Shijiazhuang, Hebei. The company operates in the manufacture of chemical raw materials and pharmaceutical preparations sector, within the broader manufacturing industry. Established 1995, the company has been operating for 31 years.

Sinolinks tracks Shiyao Group Weisheng Pharmaceutical (shijiazhuang) Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Production and sales of vitamin C raw materials (vitamin C, sodium ascorbate, calcium ascorbate), 2-keto-L-gulonic acid (non-drug), feed additives {L-ascorbic acid (vitamin C), calcium L-ascorbate, L-ascorbic acid-2-phosphate, vitamin A acetate particles 500,000, vitamin D3 particles, dl-a-tocopheryl acetate (vitamin E powder 50%), 2% d-biotin}, mixed feed additives, food additives, acquisition and export of non-quota license managed goods, non-exclusive goods. (Projects subject to approval according to law can only be carried out after approval by relevant departments)

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review